What Is the Endocannabinoid System?
The endocannabinoid system (ECS) is a complex cell-signaling network present in all vertebrates. First identified in the early 1990s by researchers studying THC, the ECS has since been recognized as one of the most critical regulatory systems in human physiology. It plays a central role in maintaining homeostasis — the body's ability to maintain stable internal conditions despite external changes.
The ECS consists of three core components: endocannabinoids (internally produced cannabinoid-like molecules), receptors that endocannabinoids bind to, and enzymes that synthesize and degrade endocannabinoids after use.
The Two Primary Receptors: CB1 and CB2
Cannabinoid receptors are found throughout the body, but the two most studied are CB1 and CB2.
CB1 receptors are concentrated primarily in the central nervous system — the brain and spinal cord — but are also present in peripheral tissues. They are involved in regulating pain perception, mood, memory, appetite, and motor function.
CB2 receptors are found predominantly in immune tissues and play a key role in modulating inflammation and immune response. CBD interacts with CB2 receptors and is associated with anti-inflammatory signaling without psychoactive effects.
Endocannabinoids: The Body's Own Cannabinoids
The body produces its own cannabinoid-like molecules called endocannabinoids. The two most studied are:
- Anandamide (AEA) — Often called the "bliss molecule," anandamide is a partial CB1 agonist associated with mood regulation, pain modulation, and neurogenesis. It is rapidly degraded by the enzyme FAAH.
- 2-Arachidonoylglycerol (2-AG) — A full agonist at both CB1 and CB2 receptors, involved in immune function, pain signaling, and synaptic plasticity.
How Phytocannabinoids Interact With the ECS
Phytocannabinoids — cannabinoids derived from plants — interact with the ECS in ways that mimic or modulate endocannabinoid activity. This is why compounds like CBD, CBG, CBN, and CBC have measurable biological effects in humans.
CBD modulates receptor sensitivity, inhibits FAAH (increasing anandamide levels), and interacts with 5-HT1A and TRPV1 receptors. CBG interacts directly with both CB1 and CB2 receptors as a partial agonist. CBN has moderate CB1 affinity and is associated with sedative effects. CBC interacts primarily with TRPV1 and TRPA1 receptors involved in pain signaling.
The Entourage Effect
Research suggests that cannabinoids and terpenes work more effectively in combination than in isolation — a phenomenon known as the entourage effect. This is the scientific rationale behind broad spectrum formulations, which retain multiple cannabinoids and terpenes while removing THC.
At cbdDR, our broad spectrum tinctures are formulated to preserve this synergistic profile while delivering standardized, verified cannabinoid concentrations in every bottle.
Why ECS Science Matters for Cannabinoid Wellness
Understanding the ECS is the foundation for making informed decisions about cannabinoid wellness. cbdDR is committed to science-first education. We don't make disease claims. We explain mechanisms, publish our lab results, and let the evidence guide the conversation.
References
- Devane WA, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949. PMID: 1470919
- Mechoulam R, Ben-Shabat S, et al. (1998). Endogenous cannabinoid ligands. Journal of Lipid Mediators and Cell Signalling, 14(1-3), 45–61. PMID: 9826784
- Zou S, Kumar U. (2018). Cannabinoid Receptors and the Endocannabinoid System. International Journal of Molecular Sciences, 19(3), 833. PMID: 29533978
- Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids. British Journal of Pharmacology, 153(2), 199–215. PMID: 17828291